APO RESEARCH · REPORT
Ampicillin
Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol).
Product & engineering
Understand the product.
Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol).
Selected research
Market Structure
Global Ampicillin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol).
China is the largest region of Ampicillin, with a market share nearly 70%. DSM, United Laboratories, CSPC Pharmaceutical, North China Pharmaceutical and Huaxing Pharmaceutical are the top 5 manufacturers of industry, and they had about 70% combined market share.
This report provides an overview of the global Ampicillin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Ampicillin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ampicillin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ampicillin market size, projected growth trends, production technologies, key applications, and end-use industries.
Ampicillin Segment by Company
DSM
ACS Dobfar
Kopran
Antibioticos
United Laboratories
Shandong Lukang
CSPC Pharmaceutical
North China Pharmaceutical
Huaxing Pharmaceutical
Ampicillin Segment by Type
Ampicillin Capsules
Ampicillin Sodium
Ampicillin Granules
Ampicillin Tablets
Ampicillin Sodium for Injection
Ampicillin Sodium and Sulbactam Sodium for Injection
Ampicillin Sodium and Cloxacillin Sodium for Injection
Others
Ampicillin Segment by Application
Adults
Kids
Ampicillin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ampicillin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ampicillin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ampicillin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ampicillin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ampicillin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ampicillin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Ampicillin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Ampicillin Capsules
- Ampicillin Sodium
- Ampicillin Granules
- Ampicillin Tablets
- Ampicillin Sodium for Injection
- Ampicillin Sodium and Sulbactam Sodium for Injection
- Ampicillin Sodium and Cloxacillin Sodium for Injection
- Others
Applications
- Adults
- Kids
Companies covered
- DSM
- ACS Dobfar
- Kopran
- Antibioticos
- United Laboratories
- Shandong Lukang
- CSPC Pharmaceutical
- North China Pharmaceutical
- Huaxing Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Ampicillin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Ampicillin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Ampicillin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Ampicillin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Ampicillin Market Dynamics
- 2.1 Ampicillin Industry Trends
- 2.2 Ampicillin Industry Drivers
- 2.3 Ampicillin Industry Opportunities and Challenges
- 2.4 Ampicillin Industry Restraints
3 Ampicillin Market by Manufacturers
- 3.1 Global Ampicillin Revenue by Manufacturers (2021-2026)
- 3.2 Global Ampicillin Sales by Manufacturers (2021-2026)
- 3.3 Global Ampicillin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Ampicillin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ampicillin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Ampicillin Manufacturers, Product Type & Application
- 3.7 Global Ampicillin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ampicillin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ampicillin Players Market Share by Revenue in 2025
- 3.8.3 2025 Ampicillin Tier 1, Tier 2, and Tier 3
4 Ampicillin Market by Type
- 4.1 Ampicillin Type Introduction
- 4.1.1 Ampicillin Capsules
- 4.1.2 Ampicillin Sodium
- 4.1.3 Ampicillin Granules
- 4.1.4 Ampicillin Tablets
- 4.1.5 Ampicillin Sodium for Injection
- 4.1.6 Ampicillin Sodium and Sulbactam Sodium for Injection
- 4.1.7 Ampicillin Sodium and Cloxacillin Sodium for Injection
- 4.1.8 Others
- 4.2 Global Ampicillin Sales by Type
- 4.2.1 Global Ampicillin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ampicillin Sales by Type (2021-2032)
- 4.2.3 Global Ampicillin Sales Market Share by Type (2021-2032)
- 4.3 Global Ampicillin Revenue by Type
- 4.3.1 Global Ampicillin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ampicillin Revenue by Type (2021-2032)
- 4.3.3 Global Ampicillin Revenue Market Share by Type (2021-2032)
5 Ampicillin Market by Application
- 5.1 Ampicillin Application Introduction
- 5.1.1 Adults
- 5.1.2 Kids
- 5.2 Global Ampicillin Sales by Application
- 5.2.1 Global Ampicillin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ampicillin Sales by Application (2021-2032)
- 5.2.3 Global Ampicillin Sales Market Share by Application (2021-2032)
- 5.3 Global Ampicillin Revenue by Application
- 5.3.1 Global Ampicillin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ampicillin Revenue by Application (2021-2032)
- 5.3.3 Global Ampicillin Revenue Market Share by Application (2021-2032)
6 Global Ampicillin Sales by Region
- 6.1 Global Ampicillin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ampicillin Sales by Region (2021-2032)
- 6.2.1 Global Ampicillin Sales by Region (2021-2026)
- 6.2.2 Global Ampicillin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ampicillin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Ampicillin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Ampicillin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Ampicillin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Ampicillin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Ampicillin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Ampicillin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Ampicillin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Ampicillin Revenue by Region
- 7.1 Global Ampicillin Revenue by Region
- 7.1.1 Global Ampicillin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Ampicillin Revenue by Region (2021-2026)
- 7.1.3 Global Ampicillin Revenue by Region (2027-2032)
- 7.1.4 Global Ampicillin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Ampicillin Revenue (2021-2032)
- 7.2.2 North America Ampicillin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Ampicillin Revenue (2021-2032)
- 7.3.2 Europe Ampicillin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Ampicillin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Ampicillin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Ampicillin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Ampicillin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 DSM
- 8.1.1 DSM Company Information
- 8.1.2 DSM Business Overview
- 8.1.3 DSM Ampicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 DSM Ampicillin Product Portfolio
- 8.1.5 DSM Recent Developments
- 8.2 ACS Dobfar
- 8.2.1 ACS Dobfar Company Information
- 8.2.2 ACS Dobfar Business Overview
- 8.2.3 ACS Dobfar Ampicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 ACS Dobfar Ampicillin Product Portfolio
- 8.2.5 ACS Dobfar Recent Developments
- 8.3 Kopran
- 8.3.1 Kopran Company Information
- 8.3.2 Kopran Business Overview
- 8.3.3 Kopran Ampicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Kopran Ampicillin Product Portfolio
- 8.3.5 Kopran Recent Developments
- 8.4 Antibioticos
- 8.4.1 Antibioticos Company Information
- 8.4.2 Antibioticos Business Overview
- 8.4.3 Antibioticos Ampicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Antibioticos Ampicillin Product Portfolio
- 8.4.5 Antibioticos Recent Developments
- 8.5 United Laboratories
- 8.5.1 United Laboratories Company Information
- 8.5.2 United Laboratories Business Overview
- 8.5.3 United Laboratories Ampicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 United Laboratories Ampicillin Product Portfolio
- 8.5.5 United Laboratories Recent Developments
- 8.6 Shandong Lukang
- 8.6.1 Shandong Lukang Company Information
- 8.6.2 Shandong Lukang Business Overview
- 8.6.3 Shandong Lukang Ampicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Shandong Lukang Ampicillin Product Portfolio
- 8.6.5 Shandong Lukang Recent Developments
- 8.7 CSPC Pharmaceutical
- 8.7.1 CSPC Pharmaceutical Company Information
- 8.7.2 CSPC Pharmaceutical Business Overview
- 8.7.3 CSPC Pharmaceutical Ampicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 CSPC Pharmaceutical Ampicillin Product Portfolio
- 8.7.5 CSPC Pharmaceutical Recent Developments
- 8.8 North China Pharmaceutical
- 8.8.1 North China Pharmaceutical Company Information
- 8.8.2 North China Pharmaceutical Business Overview
- 8.8.3 North China Pharmaceutical Ampicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 North China Pharmaceutical Ampicillin Product Portfolio
- 8.8.5 North China Pharmaceutical Recent Developments
- 8.9 Huaxing Pharmaceutical
- 8.9.1 Huaxing Pharmaceutical Company Information
- 8.9.2 Huaxing Pharmaceutical Business Overview
- 8.9.3 Huaxing Pharmaceutical Ampicillin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Huaxing Pharmaceutical Ampicillin Product Portfolio
- 8.9.5 Huaxing Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ampicillin Value Chain Analysis
- 9.1.1 Ampicillin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ampicillin Production Mode & Process
- 9.2 Ampicillin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ampicillin Distributors
- 9.2.3 Ampicillin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst